Resmed (RSMDF) Cash from Investing Activities (2009 - 2026)

Resmed has reported Cash from Investing Activities for 18 years, with the latest figure at -$58.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 82.56% year-over-year to -$58.0 million; the trailing twelve-month figure through Mar 2026 stood at -$295.3 million (down 161.66% YoY), and the FY2025 full-year result was -$200.0 million, up 25.85% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$58.0 million, down from -$50.9 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $2.1 million in Q3 2024, with the low at -$1.0 billion in Q4 2022.
• Historically, Cash from Investing Activities has averaged -$111.5 million across 5 years, with a median of -$49.5 million in 2022.
• Annual changes were most pronounced in 2024 — Cash from Investing Activities jumped 101.44% — and 2025, when it sank 2550.05%.
• Resmed's Cash from Investing Activities stood at -$1.0 billion in 2022, then jumped by 95.99% to -$41.1 million in 2023, then rose by 10.82% to -$36.7 million in 2024, then tumbled by 38.84% to -$50.9 million in 2025, then dropped by 13.91% to -$58.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$58.0 million (Q1 2026), -$50.9 million (Q4 2025), and -$52.6 million (Q3 2025), per Business Quant data.